2019 – Policy & Medicine

Study Finds that CE Increases Provider Competence

Senate Finance Committee Releases Updated Drug Pricing Bill and Extender Agreement

Deval Patrick: Will Healthcare Ties Help His Campaign?

Analysis of Accountable Care Organizations Shows Significant Savings

CMS Survey of 340B Drug Prices Garners Hospital Pushback

HHS and FDA Unveil Proposed Rules on Drug Importations

FDA Guidance on Adaptive Clinical Trials Design

Biologic Exclusivity Provision Removed from USCMA Agreement

FDA Releases Report on Drug Shortages and Encourages Manufacturer Quality Rating System

Insys Executives’ Convictions Partially Overturned